Allakos
ALLK
ALLK was delisted on the 15th of May, 2025.
130 hedge funds and large institutions have $304M invested in Allakos in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 23 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 36
5% more call options, than puts
Call options by funds: $78K | Put options by funds: $74K
0% more funds holding
Funds holding: 130 → 130 (0)
0% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 23
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
48% less capital invested
Capital invested by funds: $584M → $304M (-$280M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
+$7.6M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$6.74M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.18M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.35M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$23.5M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$8.41M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$7.75M |
| 4 |
ABG
Ally Bridge Group
New York
|
-$5.24M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$4.85M |
ALLK Hedge Fund Activity: Q1 2023 in Review
130 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Allakos (ALLK) for Q1 2023, worth a combined $304M — down 48% from $584M a quarter earlier.
Fund positioning in ALLK was balanced in Q1 2023: 23 funds opened new positions, 23 closed out, 48 added to existing stakes and 36 trimmed.
The largest buyer was Blackstone Inc, adding an estimated $7.6M. The largest seller was Frazier Life Sciences Management, cutting an estimated $23.5M.
- 130 institutional investors held Allakos (ALLK) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $304M of Allakos stock for Q1 2023, down 48% quarter-over-quarter.
- 23 funds opened new Allakos positions in Q1 2023 and 23 closed out, a net change of 0 holders.
- The largest Allakos buyer in Q1 2023 was Blackstone Inc, an estimated $7.6M added.
- The largest Allakos seller in Q1 2023 was Frazier Life Sciences Management, an estimated $23.5M sold.
Based on aggregated 13F filings for Q1 2023.